JP2006503806A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503806A5 JP2006503806A5 JP2004508780A JP2004508780A JP2006503806A5 JP 2006503806 A5 JP2006503806 A5 JP 2006503806A5 JP 2004508780 A JP2004508780 A JP 2004508780A JP 2004508780 A JP2004508780 A JP 2004508780A JP 2006503806 A5 JP2006503806 A5 JP 2006503806A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- preparation according
- active substance
- ion exchanger
- substance bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 239000013543 active substance Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 238000005342 ion exchange Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical group C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- 239000000440 bentonite Substances 0.000 claims 1
- 229910000278 bentonite Inorganic materials 0.000 claims 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims 1
- 229920003086 cellulose ether Polymers 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960000740 enrofloxacin Drugs 0.000 claims 1
- 239000006194 liquid suspension Substances 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000004584 polyacrylic acid Substances 0.000 claims 1
- 229960001248 pradofloxacin Drugs 0.000 claims 1
- LZLXHGFNOWILIY-APPDUMDISA-N pradofloxacin Chemical group C12=C(C#N)C(N3C[C@H]4NCCC[C@H]4C3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 LZLXHGFNOWILIY-APPDUMDISA-N 0.000 claims 1
- 239000003306 quinoline derived antiinfective agent Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224086A DE10224086A1 (de) | 2002-05-31 | 2002-05-31 | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| DE10224086.8 | 2002-05-31 | ||
| PCT/EP2003/005228 WO2003101422A2 (de) | 2002-05-31 | 2003-05-19 | Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010235021A Division JP2011012087A (ja) | 2002-05-31 | 2010-10-20 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006503806A JP2006503806A (ja) | 2006-02-02 |
| JP2006503806A5 true JP2006503806A5 (https=) | 2006-07-06 |
| JP5350574B2 JP5350574B2 (ja) | 2013-11-27 |
Family
ID=29432468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004508780A Expired - Lifetime JP5350574B2 (ja) | 2002-05-31 | 2003-05-19 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
| JP2010235021A Withdrawn JP2011012087A (ja) | 2002-05-31 | 2010-10-20 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010235021A Withdrawn JP2011012087A (ja) | 2002-05-31 | 2010-10-20 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8545829B2 (https=) |
| EP (1) | EP1513500B1 (https=) |
| JP (2) | JP5350574B2 (https=) |
| KR (3) | KR101258373B1 (https=) |
| CN (1) | CN1671361B (https=) |
| AR (2) | AR039861A1 (https=) |
| AT (1) | ATE421317T1 (https=) |
| AU (1) | AU2003242545B2 (https=) |
| BR (2) | BR0311511A (https=) |
| CA (1) | CA2487648C (https=) |
| CR (1) | CR7598A (https=) |
| DE (2) | DE10224086A1 (https=) |
| DK (1) | DK1513500T3 (https=) |
| ES (1) | ES2319115T3 (https=) |
| HR (1) | HRP20041219B1 (https=) |
| IL (2) | IL165322A0 (https=) |
| MX (1) | MXPA04011820A (https=) |
| MY (1) | MY140953A (https=) |
| NO (1) | NO333939B1 (https=) |
| PL (1) | PL207269B1 (https=) |
| PT (1) | PT1513500E (https=) |
| RU (1) | RU2380091C2 (https=) |
| SI (1) | SI1513500T1 (https=) |
| TW (1) | TWI333422B (https=) |
| UA (1) | UA84270C2 (https=) |
| WO (1) | WO2003101422A2 (https=) |
| ZA (1) | ZA200409616B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
| WO2006061700A2 (en) * | 2004-12-06 | 2006-06-15 | Themis Laboratories Private Limited | Rapid disintegrating taste masked compositions and a process for its preparations |
| DE102005025900A1 (de) * | 2005-06-06 | 2006-12-07 | Basf Ag | Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch |
| US20080051332A1 (en) * | 2005-11-18 | 2008-02-28 | Nastech Pharmaceutical Company Inc. | Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| CN100360131C (zh) * | 2006-01-24 | 2008-01-09 | 新昌国邦化学工业有限公司 | 一种掩味恩诺沙星的生产方法 |
| US20070248564A1 (en) * | 2006-04-25 | 2007-10-25 | Roxane Laboratories, Inc. | Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia |
| EP2066302A2 (en) | 2006-09-26 | 2009-06-10 | Taro Pharmaceuticals North America, Inc. | Stabilizing compositions for antibiotics and methods of use |
| DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| US20080118570A1 (en) * | 2006-11-20 | 2008-05-22 | Zhi Liu | Polymer coated drug-ion exchange resins and methods |
| CN102046202A (zh) * | 2008-03-26 | 2011-05-04 | 塔罗制药北美有限公司 | 用于口服药剂的稳定脂质组合物 |
| ES2626151T3 (es) | 2010-03-12 | 2017-07-24 | Monsanto Technology Llc | Composiciones agroquímicas en gel |
| TW201208684A (en) * | 2010-05-19 | 2012-03-01 | Astellas Pharma Inc | Pharmaceutical composition comprising solifenacin |
| CA2852447A1 (en) | 2011-10-19 | 2013-04-25 | R.P. Scherer Technologies, Llc | Two phase pharmaceutical delivery system |
| FR2998305B1 (fr) * | 2012-11-22 | 2015-02-20 | Henkel Ag & Co Kgaa | Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire |
| KR101697095B1 (ko) * | 2015-09-30 | 2017-01-18 | 주식회사 포스코 | 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크 |
| CA3098060A1 (en) | 2018-04-25 | 2019-10-31 | Bayer Animal Health Gmbh | Process for the hydrolysis of quinolone carboxylic esters |
| KR102923598B1 (ko) * | 2019-07-15 | 2026-02-09 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 포함하는 액상 시럽제제 및 이의 제조방법 |
| CN114249749B (zh) * | 2022-01-08 | 2024-03-22 | 天象生物药业邢台有限责任公司 | 一种马波沙星甲酸盐的转化方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US614622A (en) * | 1898-11-22 | Machine for making billets | ||
| JPS60204713A (ja) | 1984-03-30 | 1985-10-16 | Zenyaku Kogyo Kk | 水性懸濁組成物 |
| GB8618847D0 (en) * | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US5338732A (en) * | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| AU2884892A (en) * | 1991-10-28 | 1993-06-07 | Procter & Gamble Company, The | Beverage thickener/emulsifier system |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
| ATE228130T1 (de) * | 1996-02-23 | 2002-12-15 | Bayer Ag | Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3- hinolincarbonsäuren und ihre derivate |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| HUP0202229A3 (en) * | 1999-07-14 | 2008-10-28 | Schering Plough Ltd | Oral liquid pharmaceutical compositions containing quinolone derivatives and ion exchange resins as taste mashing |
| GB9930058D0 (en) * | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| GB0020089D0 (en) | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| DE10134719A1 (de) * | 2001-07-17 | 2003-02-06 | Bayer Ag | Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze |
| US7001667B2 (en) * | 2002-07-17 | 2006-02-21 | Ppg Industries Ohio, Inc. | Alkyd-based free radical wood coating compositions |
-
2002
- 2002-05-31 DE DE10224086A patent/DE10224086A1/de not_active Withdrawn
-
2003
- 2003-05-19 ES ES03755931T patent/ES2319115T3/es not_active Expired - Lifetime
- 2003-05-19 IL IL16532203A patent/IL165322A0/xx unknown
- 2003-05-19 KR KR1020117031524A patent/KR101258373B1/ko not_active Expired - Lifetime
- 2003-05-19 PT PT03755931T patent/PT1513500E/pt unknown
- 2003-05-19 KR KR10-2004-7019371A patent/KR20050010015A/ko not_active Ceased
- 2003-05-19 RU RU2004139022/15A patent/RU2380091C2/ru active
- 2003-05-19 DK DK03755931T patent/DK1513500T3/da active
- 2003-05-19 DE DE50311123T patent/DE50311123D1/de not_active Expired - Lifetime
- 2003-05-19 BR BR0311511-9A patent/BR0311511A/pt active IP Right Grant
- 2003-05-19 AT AT03755931T patent/ATE421317T1/de active
- 2003-05-19 KR KR1020127026888A patent/KR20120123607A/ko not_active Ceased
- 2003-05-19 WO PCT/EP2003/005228 patent/WO2003101422A2/de not_active Ceased
- 2003-05-19 SI SI200331534T patent/SI1513500T1/sl unknown
- 2003-05-19 AU AU2003242545A patent/AU2003242545B2/en not_active Expired
- 2003-05-19 BR BRPI0311511-9A patent/BRPI0311511B1/pt unknown
- 2003-05-19 EP EP03755931A patent/EP1513500B1/de not_active Expired - Lifetime
- 2003-05-19 PL PL373456A patent/PL207269B1/pl unknown
- 2003-05-19 UA UA20041210942A patent/UA84270C2/ru unknown
- 2003-05-19 US US10/516,344 patent/US8545829B2/en not_active Expired - Fee Related
- 2003-05-19 JP JP2004508780A patent/JP5350574B2/ja not_active Expired - Lifetime
- 2003-05-19 HR HRP20041219AA patent/HRP20041219B1/hr not_active IP Right Cessation
- 2003-05-19 MX MXPA04011820A patent/MXPA04011820A/es active IP Right Grant
- 2003-05-19 CN CN038182106A patent/CN1671361B/zh not_active Expired - Lifetime
- 2003-05-19 CA CA2487648A patent/CA2487648C/en not_active Expired - Lifetime
- 2003-05-28 AR ARP030101867A patent/AR039861A1/es not_active Application Discontinuation
- 2003-05-29 MY MYPI20031984A patent/MY140953A/en unknown
- 2003-05-30 TW TW092114643A patent/TWI333422B/zh not_active IP Right Cessation
-
2004
- 2004-11-22 IL IL165322A patent/IL165322A/en active IP Right Grant
- 2004-11-24 CR CR7598A patent/CR7598A/es not_active Application Discontinuation
- 2004-11-29 ZA ZA200409616A patent/ZA200409616B/xx unknown
- 2004-12-29 NO NO20045700A patent/NO333939B1/no not_active IP Right Cessation
-
2010
- 2010-10-20 JP JP2010235021A patent/JP2011012087A/ja not_active Withdrawn
-
2016
- 2016-08-23 AR ARP160102580A patent/AR105798A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503806A5 (https=) | ||
| CN101711752B (zh) | 一种苯并异噁唑类衍生物的控释制剂及其制备方法 | |
| CA2487648A1 (en) | Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents | |
| CN102083467B (zh) | 固体分散体及其药物组合物、以及它们的制备方法 | |
| ES2241931T3 (es) | Suspension de fenofibrato en una solucion de polimero hidrofilo. | |
| CN100562317C (zh) | 含大量酸不稳定药物的颗粒 | |
| JPS62123112A (ja) | 軟膏基剤 | |
| JP2009545560A5 (https=) | ||
| RU2009141538A (ru) | Твердые лекарственные формы, содержащие тадалафил | |
| ES2750323T3 (es) | Método para la fabricación de un comprimido mediante radiofrecuencia y partículas recubiertas con pérdida | |
| CA2503361A1 (en) | Controlled-release compositions | |
| JP2006514967A5 (https=) | ||
| CN103284962B (zh) | 莫西沙星分散片及制备方法 | |
| EP2393486A1 (en) | Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process | |
| CN106794142A (zh) | 核心组合物 | |
| JP5721093B2 (ja) | 崩壊錠 | |
| WO2014111799A1 (es) | Composición de difenidol de liberación prolongada | |
| TW201212953A (en) | Coating agent for solid pharmaceutical preparation, film coating preparation for pharmaceutical use and coated solid pharmaceutical preparation | |
| WO2011079764A1 (zh) | 一种右旋佐匹克隆固体制剂及其制备方法 | |
| JP2005500332A5 (https=) | ||
| JP4165224B2 (ja) | 発泡性組成物 | |
| CN102697751A (zh) | 一种畜禽专用恩诺沙星泡腾分散片及其制备方法 | |
| CN101890013A (zh) | 用碱性试剂稳定的匹伐他汀钙组合物及其制备方法 | |
| JP4965096B2 (ja) | 圧縮成型製剤 | |
| CN105412037B (zh) | 一种罗红霉素缓控释制剂 |